Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC, a growing consumer healthcare group, has announced that their preliminary results for the fiscal year ending December 31, 2023, will be published on May 8, 2024, with an analyst meeting to follow. Interested parties can attend the meeting in person or watch a live webcast, with a recording available afterwards on the company’s investor website. The company emphasizes its growth strategy through brand investment, innovation, and potential strategic acquisitions, operating with an asset-light model across various global locations.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
